McDonagh TA, Metra M, Adamo M, et al. 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37):3627–39. https://doi.org/10.1093/eurheartj/ehad195.

Article  CAS  PubMed  Google Scholar 

Norhammar A, Bodegard J, Vanderheyden M, et al. Prevalence, outcomes and costs of a contemporary, multinational population with heart failure. Heart. 2023;109(7):548–56. https://doi.org/10.1136/heartjnl-2022-321702.

Article  PubMed  Google Scholar 

Conrad N, Judge A, Tran J, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet. 2018;391(10120):572–80. https://doi.org/10.1016/S0140-6736(17)32520-5.

Article  PubMed  PubMed Central  Google Scholar 

Khan MS, Shahid I, Bennis A, et al. Global epidemiology of heart failure. Nat Rev Cardiol. 2024;21(10):717–34. https://doi.org/10.1038/s41569-024-01046-6.

Article  PubMed  Google Scholar 

Zarrinkoub R, Wettermark B, Wandell P, et al. The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. Eur J Heart Fail. 2013;15(9):995–1002. https://doi.org/10.1093/eurjhf/hft064.

Article  PubMed  Google Scholar 

Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3(1):7–11. https://doi.org/10.15420/cfr.2016:25:2.

Article  PubMed  PubMed Central  Google Scholar 

Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure. J Card Fail. 2017;23(8):628–51. https://doi.org/10.1016/j.cardfail.2017.04.014.

Article  PubMed  Google Scholar 

Mann DL. Mechanisms and models in heart failure: a combinatorial approach. Circulation. 1999;100(9):999–1008. https://doi.org/10.1161/01.cir.100.9.999.

Article  CAS  PubMed  Google Scholar 

Mann DL, Felker GM. Mechanisms and models in heart failure: a translational approach. Circ Res. 2021;128(10):1435–50. https://doi.org/10.1161/CIRCRESAHA.121.318158.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161–7. https://doi.org/10.1056/NEJMoa020233.

Article  CAS  PubMed  Google Scholar 

Pan JA, Kramer CM. Cardiac magnetic resonance imaging in heart failure. Cardiovasc Innov Appl. 2024. https://doi.org/10.15212/cvia.2024.0037.

Article  PubMed  PubMed Central  Google Scholar 

Berg DD, Patel SM, Haller PM, et al. Dapagliflozin in patients hospitalized for heart failure: primary results of the DAPA ACT HF-TIMI 68 randomized clinical trial and meta-analysis of sodium-glucose cotransporter-2 inhibitors in patients hospitalized for heart failure. Circulation. 2025. https://doi.org/10.1161/CIRCULATIONAHA.125.076575.

Article  PubMed  Google Scholar 

Cleland JGF, Bristow MR, Freemantle N, et al. The effect of cardiac resynchronization without a defibrillator on morbidity and mortality: an individual patient data meta-analysis of COMPANION and CARE-HF. Eur J Heart Fail. 2022;24(6):1080–90. https://doi.org/10.1002/ejhf.2524.

Article  CAS  PubMed  Google Scholar 

Stewart S, MacIntyre K, Hole DJ, et al. More ‘malignant’ than cancer? Five‐year survival following a first admission for heart failure. Eur J Heart Fail. 2001;3(3):315–22. https://doi.org/10.1016/s1388-9842(00)00141-0.

Article  CAS  PubMed  Google Scholar 

Bleumink GS, Knetsch AM, Sturkenboom MC, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J. 2004;25(18):1614–9. https://doi.org/10.1016/j.ehj.2004.06.038.

Article  PubMed  Google Scholar 

Lesyuk W, Kriza C, Kolominsky-Rabas P. Cost-of-illness studies in heart failure: a systematic review 2004–2016. BMC Cardiovasc Disord. 2018;18(1):74. https://doi.org/10.1186/s12872-018-0815-3.

Article  PubMed  PubMed Central  Google Scholar 

Cook C, Cole G, Asaria P, et al. The annual global economic burden of heart failure. Int J Cardiol. 2014;171(3):368–76. https://doi.org/10.1016/j.ijcard.2013.12.028.

Article  PubMed  Google Scholar 

Lesyuk W, Kriza C, Kolominsky-Rabas PL. A systematic review of cost-of-illness studies in chronic heart failure. Value Health. 2014;17(7):A484. https://doi.org/10.1016/j.jval.2014.08.1411.

Article  CAS  PubMed  Google Scholar 

Urbich M, Globe G, Pantiri K, et al. A systematic review of medical costs associated with heart failure in the USA (2014–2020). Pharmacoeconomics. 2020;38(11):1219–36. https://doi.org/10.1007/s40273-020-00952-0.

Article  PubMed  PubMed Central  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71.

Article  PubMed  PubMed Central  Google Scholar 

Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2025. Accessed 24 March 2025. DOI:

Gunn AH, Warraich HJ, Mentz RJ. Costs of care and financial hardship among patients with heart failure. Am Heart J. 2024;269:94–107. https://doi.org/10.1016/j.ahj.2023.12.001.

Article  PubMed  Google Scholar 

Li Y, Levy W, Neilson M, et al. Associations between Seattle Heart Failure Model scores and medical resource use and costs: findings from HF-ACTION. J Card Fail. 2014;20(8):541–7. https://doi.org/10.1016/j.cardfail.2014.05.009.

Article  PubMed  PubMed Central  Google Scholar 

Martin S, Aday A, Allen N, et al. 2025 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2025. https://doi.org/10.1161/CIR.0000000000001303.

Article  PubMed  Google Scholar 

Tsao C, MDM, FAHAC, et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. 2022;145(8):e153-e639. https://doi.org/10.1161/CIR.0000000000001052.

Virani S, MDP, FAHAC, et al. Heart disease and stroke statistics-2020 update: a report from the Am Heart Assoc. 2020;141(9):e139-e51. https://doi.org/10.1161/CIR.0000000000000757.

Ambrosy A, Fonarow G, Butler J, et al. The global health and economic burden of hospitalizations for heart failure lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63(12):1123–33. https://doi.org/10.1016/j.jacc.2013.11.053.

Article  PubMed  Google Scholar 

Aras D, Aydogdu S, Bozkurt E, et al. Cost of heart failure management in Turkey: results of a Delphi panel. Anatol J Cardiol. 2016;16(8):554–62. https://doi.org/10.14744/AnatolJCardiol.2016.6999.

Article  PubMed  PubMed Central  Google Scholar 

Bueno H, Bernal JL, Jimenez-Jimenez V, et al. The clinical outcomes, healthcare resource utilization, and related costs (COHERENT) model. Application in heart failure patients. Revista Española de Cardiología (English Edition). 2022;75(7):585–94. https://doi.org/10.1016/j.rec.2021.08.009.

Article  Google Scholar 

Bueno H, Goni C, Salguero-Bodes R, et al. Primary vs. secondary heart failure diagnosis: differences in clinical outcomes, healthcare resource utilization and cost. Front Cardiovasc Med. 2022;9:818525. https://doi.org/10.3389/fcvm.2022.818525.

Article  PubMed  PubMed Central  Google Scholar 

Cavusoglu Y, Altay H, Aras D, et al. Cost-of-disease of heart failure in Turkey: a Delphi panel-based analysis of direct and indirect costs. Balkan Med J. 2022;39(4):282–9. https://doi.org/10.4274/balkanmedj.galenos.2022.2022-3-97.

Article  PubMed  PubMed Central  Google Scholar 

Figueroa JF, Papanicolas I, Riley K, et al. International comparison of health spending and utilization among people with complex multimorbidity. Health Serv Res. 2021;56:1317–34. https://doi.org/10.1111/1475-6773.13708.

Article